Thirty-day results from prospective multi-specialty evaluation of carotid artery stenting using the CGuard MicroNet-covered Embolic Prevention System in real-world multicentre clinical practice: the IRON-Guard study

Francesco Speziale1, MD; Laura Capoccia1*, MD; Pasqualino Sirignano1, MD; Wassim Mansour1, MD; Chiara Pranteda1, MD; Renato Casana2, MD; Carlo Setacci3, MD; Federico Accrocca4, MD; Domenico Alberti5, MD; Gianmarco de Donato3, MD; Michelangelo Ferri6, MD; Andrea Gaggiano7, MD; Giuseppe Galzerano3, MD; Arnaldo Ippoliti8, MD; Nicola Mangialardi9, MD; Giovanni Pratesi8, MD; Sonia Ronchey9, MD; Maria Antonella Ruffino10, MD; Andrea Siani4

1. Vascular and Endovascular Surgery Division, Department of Surgery “Paride Stefanini”, Policlinico Umberto I, “Sapienza” University of Rome, Rome, Italy; 2. Vascular and Endovascular Surgery Unit, Istituto Auxologico IRCCS, Milan, Italy; 3. Vascular and

Aims: The aim of the present study was to evaluate periprocedural and 30-day outcomes in a prospective series of patients treated with the CGuard Embolic Prevention System (EPS).

Sign in to read and download the full article

Login Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

carotid and supra-aortic diseaseclinical trialstroke

Share on Facebook Share on Twitter Share on Linkedin

Read next article

Catheter-based therapies in acute pulmonary embolism